treat various bacterial infections which for many years now are known as phage therapy. The ability of these phages to multiply in vivo, requiring very low initial dosage, their unharmful ... recombination in a phage…
enzymes, antimicrobial peptides, growth factors, and wound healing agents. However, the use of maggot therapy is an effective method of wound healing. But, this method has limitations such as disgust ... Therefore…
occur with any inhaled agent and may be a reason for discontinuation of inhalation therapy in cystic fibrosis (CF) patients. On the other hand, inhalation of antibiotics is being increasingly ... itself, such as the…
Alteplase (recombinant tissue plasminogen activator) is the only licensed drug for acute ischemic stroke (AIS) treatment, but only 3–5% of patients with AIS receive thrombolytic treatment using alteplase. Further…
Objective: To evaluate benefits of Recombinant Adeno-viral Human p53 (rAd-p53) gene therapy combined with radiotherapy in prevention of oral cancer recurrence after a radical resection. Methods: A total
descriptive, retrospective case series was to determine the efficacy of recombinant human epidermal growth factor (rhEGF) plus compression therapy vs standard of care in 48 patients with active ulcers resulting
inhibitors have emerged as a significant class of targeted therapies in oncology, particularly in the treatment of cancers with homologous recombination deficiency, such as those with BRCA mutations. This review
plant toxin ricin fused to a 6xHis tag in the C-terminus. The soluble recombinant protein T22mRTAH6 spontaneously self assembled as protein-only regular nanoparticles of about 12nm in size ... organs. The functionalized…
treating complex diseases. Unlike conventional drugs, biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and gene therapies are derived from living organisms, making them highly specific and…
Targeted therapy of cancer is getting more traction over the traditional chemotherapy to overcome the unavoidable side effects from the chemotherapeutic drugs. As scientists began to understand more about ... toxic…
increased specificity, potency, and reduced immunogenicity. Key development platforms, including recombinant DNA technology, monoclonal antibody technology, gene therapy, and cell therapy, have paved the way for…
increased specificity, potency, and reduced immunogenicity. Key development platforms, including recombinant DNA technology, monoclonal antibody technology, gene therapy, and cell therapy, have paved the way for…
increased specificity, potency, and reduced immunogenicity. Key development platforms, including recombinant DNA technology, monoclonal antibody technology, gene therapy, and cell therapy, have paved the way for…
repair deficiencies in up to 50% of cases, particularly in BRCA-mutated and homologous recombination-deficient (HRD) tumors. Poly (ADPribose) polymerase (PARP) inhibitors, such as olaparib, niraparib, and rucaparib…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.